Pharmaceutical Technology

NOVEMBER 25, 2022

Market Research Analysts and Marketing Specialists came in second with a share of 6% in Q3 2022, with new job postings rise by 18% over the previous quarter. The global pharmaceutical industry experienced a 5% rise in new job postings related to digital media in Q3 2022 compared with the previous quarter, according to GlobalData’s Jobs Analytics. This compares to a 5% increase in the previous quarter and an 166% increase versus Q3 2021.

Research Analyst 100

Research Analyst Sales Marketing Research 100

The Pharma Data

AUGUST 20, 2020

The latest results underscore that large pharma companies are making a “strategic retreat from some of their older drugs,” in China, ICBC International Research analyst Zhang Jialin said, as quoted by Bloomberg; instead, they’re focusing on growing market share for newer medicines.

Research Analyst 52

Research Analyst Medicine Pharma Companies Marketing 52

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”.

Research Analyst 130

Research Analyst Manufacturing FDA Approval Drugs 130

XTalks

APRIL 13, 2021

Kyle Gaan, a research analyst at GFI said in the same press release, “2020 was a breakout year for plant-based foods across the store.

Sales 83

Sales Research Analyst Marketing Production 83

XTalks

JUNE 9, 2022

Tirzepatide’s continuing stellar trial results as a weight loss injection have industry analysts putting up big predictions for the drug, particularly as a rival to Novo’s obesity drug Wegovy (tirzepatide is currently only approved for the treatment of type 2 diabetes under the trade name Mounjaro).

Research Analyst 52

Research Analyst Sales Drugs Medicine 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. Prior to that, Dr. Zhang was an equity research analyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. SHANGHAI and SYDNEY , Dec.

Research Analyst 40

Research Analyst Clinical Trials Clinical Trials Branding 40

The Pharma Data

DECEMBER 31, 2020

Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. Prior to Raptor, Lee was a biotechnology sell-side analyst at investment banks, including Jefferies and Wedbush Securities.

Gene Therapy 52

Gene Therapy Research Analyst Gene Engineer 52